Fentanyl SublingualIn Breakthrough Pain in Opioid-Tolerant Adults with Cancer

被引：0
作者：
Claudine M. Chwieduk
Kate McKeage
机构：
[1] Adis,
[2] a Wolters Kluwer Business,undefined
来源：
Drugs | 2010年 / 70卷
关键词：
Fentanyl; Breakthrough Pain; Primary Efficacy Variable; Pain Intensity Difference; Sublingual Mucosa;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Fentanyl is a potent opioid with a short duration of action. Fentanyl sublingual has been formulated as a rapidly disintegrating tablet that is quickly absorbed, producing a fast onset of analgesia.
引用
收藏
页码：2281 / 2288
页数：7
相关论文
共 63 条
  • [1] Portenoy RK(1999)Breakthrough pain: characteristics and impact in patients with cancer pain Pain 81 129-34
  • [2] Payne D(2000)Breakthrough cancer pain: epidemiology, characteristics and management CNS Drugs 13 313-9
  • [3] Jacobsen P(1999)Management of cancer pain Lancet 353 1695-700
  • [4] Fine PG(2005)World Health Organization guidelines for cancer pain: a reappraisal Ann Oncol 16 iv132-5
  • [5] Portenoy RK(2001)Morphine and alternative opioids in cancer pain: the EAPC recommendations Br J Cancer 84 587-93
  • [6] Lesage P(2009)The management of cancer-related breakthrough pain: recommendations of a task group of the science committee of the association for palliative medicine of Great Britain and Ireland Eur J Pain 13 331-8
  • [7] Mercadante S(2009)Novel formulations and routes of administration for opioids in the treatment of breakthrough pain Therapy 6 695-706
  • [8] Fulfaro F(2006)Fentanyl buccal tablet: in breakthrough pain in opioid-tolerant patients with cancer Drugs 66 2387-93
  • [9] Hanks GW(2008)Management of breakthrough pain in patients with cancer Drugs 68 913-24
  • [10] de Conno F(2010)Formulations of fentanyl for the management of pain Drugs 70 57-72
1234567